Adicet Bio stockholders elect three Class II directors, approve say-on-pay, ratify KPMG

Adicet Bio, Inc.

All three Class II director nominees elected: Chodakewitz, Dubin, Grissinger, each with 86-98% of votes cast.
Non-binding advisory vote on executive compensation approved with ~86% of votes cast in favor.
Ratification of KPMG as independent auditor for FY2026 passed with 99.6% of votes cast in favor.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adicet Bio, Inc. shareholders approved Non-Binding Advisory Vote on Compensation of the Company’s Named Executive Officers at the 2026-06-17 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

Votes For Votes Against Abstain Broker Non-Votes 4,611,540 745,537 4,939 1,384,153

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adicet Bio, Inc. shareholders approved Election of Class II Director Nominees at the 2026-06-17 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

Name Votes For Votes Withheld Broker Non-Votes Jeffrey Chodakewitz 4,629,969 732,047 1,384,153 Steve Dubin 4,596,116 765,900 1,384,153 Michael Grissinger 5,257,041 104,975 1,384,153

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adicet Bio, Inc. shareholders approved Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

Votes For Votes Against Abstain Broker Non-Votes 6,719,352 25,206 1,611 N/A

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Adicet Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001720580-26-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.